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Abstract
Purpose: To evaluate time savings, efficiency, and accuracy of an automated planning software.
Methods: 10 previously treated breast cancer patients with supraclavicular involvement were
retrospectively planned using a monosiocentric field-in-field technique by both an automated
treatment planning software and a human planner. Time spent on planning was recorded and
after plans were generated, dose constraints and target coverage were measured to evaluate
overall plan quality.
Results: Time spent for planning was significantly decreased when using a FIF plan generated
by the automated planning software. CTV target coverage for both the breast and
supraclavicular volumes and dose to OARs for both plans were clinically comparable. The
plans generated by EZFluence did have a significantly higher amount of 5350 cGy contained
within the plan compared to the manually created FIF plan.
Conclusion: While EZFluence greatly reduced overall planning time and produced clinically
acceptable plans, the generated plans had a higher hot spot and a higher volume of 5350 cGy
within the plan.
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Introduction/Literature Review
Breast cancer is the most common form of cancer diagnosed in women, aside from some
forms of skin cancer and is the second most common form of death related to cancer malignancy.
An estimated 1 in 8 women will be diagnosed with breast cancer at some point in their lives and
around 281,550 new cases of invasive breast cancer and 49,290 new cases of non-invasive, or insitu, breast cancer will be diagnosed in women in 20211,2. The incidence rates of breast cancer
have been increasing by 0.5% per year. Despite the increased incident rate, death rates have
decreased by 1% from 2013-20181. Better screening methods, such as mammography and selfexaminations, attribute to the positive outcomes. There has also been an increased awareness
among the general population about breast cancer. From 1989 to 2018, early detection
techniques and overall treatment improvements have resulted in a 41% decrease in the number of
deaths due to breast cancer2.
Radiation therapy is commonly used for breast cancer treatment in conjunction with
surgery, hormone therapy, and/or chemotherapy. Radiation therapy works by using x-rays to
destroy DNA inside cancer cells. For breast cancer, radiation is typically prescribed to be given
following surgery. The prescribed dose and treatment volumes depend on tumor size and spread
of disease. The primary route of spread for breast cancer is to the axillary lymph nodes,
supraclavicular lymph nodes, and internal mammary lymph nodes3. Per the National
Comprehensive Cancer Network (NCCN), doses to the regional nodal fields is between 45 and
50.4 Gy received in 25 to 28 fractions respectfully. Two studies, MA.20 and EORTC
22922/10925, evaluate nodal radiation therapy in addition to whole breast or chest wall radiation
following surgery. The studies conclude that regional recurrences are lower when nodal
irradiation is completed than when it is not completed. It is shown by the study that disease-free
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survival increases by 5 percent over a 10-year time frame when patients receive nodal radiation.
The NCCN recommends that the infraclavicular and supraclavicular areas, internal mammary
nodes and any part of the axillary bed that contains 4 or more positive lymph nodes be irradiated
after a lumpectomy to reduce the risk of locoregional and distant recurrence and to improve
disease-free survival4.
Radiation therapy treatment planning can be complicated when the supraclavicular lymph
nodes are involved. During field setup, a monoisocentric 3-field approach is commonly used and
consists of two opposing tangential fields and an anterior supraclavicular field. Care is taken to
eliminate overlap between the tangential and supraclavicular fields by using a half-beam block
technique. This technique closes the inferior Y-jaw for the supraclavicular field and the superior
Y-jaw for the tangential fields. The tangential fields are matched at their non-divergent borders
to eliminate dose to the lungs and heart.
After the initial fields are created, a dose distribution can be visualized. Due to the shape
of the breast, there will be hot spots at the apex of the breast tissue and laterally where there is
less tissue to traverse. Field-in-field (FIF) technique is a forward planning technique that utilizes
the multileaf collimators (MLCs) to create subfields within each primary tangent field. These
subfields minimize hot spots and dose to organs at risk, such as the heart and lungs while also
creating a more conformal dose to the targets. This is accomplished by isolating high dose levels
and using the MLCs and beam weighting to eliminate the dose level one subfield at a time. This
process is repeated until a more homogeneous plan is created. The goal is to eliminate as much
dose over 105% as possible, while also keeping a homogeneous dose distribution to the targets5.
Artificial Intelligence (AI) is a technological advancement for radiation therapy treatment
planning. It is defined as “the study of algorithms and devices that perceive information from
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the environment and take action to maximize the chance of achieving specific goals”6. AI has
been introduced into radiation oncology through scripts that assist in imaging, contouring, and
planning. The AI techniques strive to find the most optimal solution that meets the objectives,
which is delivering 100% of the prescribed dose to the target while sparing dose to the
surrounding OARs. Although accurate, these plans are not always perfect and may still require
fine-tuning by medical dosimetrists, which requires extra time and effort7. Artificial intelligence
is extremely helpful in improving efficiency by completing the tasks that are repetitive and time
consuming, while also eliminating errors due to intra- and inter-observer variability. A study
completed at the Princess Margaret Hospital evaluated the efficiency of automated treatment
planning for breast using Intensity Modulated Radiation Therapy (IMRT) and showed an
improvement in quality of the treatment plan as well as efficiency over the current process of
manual treatment planning. Similar results were concluded with breast cancer that also included
nodal involvement. Researchers concluded that when automatically generated Volumetric Arc
Therapy (VMAT) were compared to manually created plans, the dose distributions were similar,
but the time savings effect was much greater for the automatically generated plans8.
EZFluence is one version of auto-planning scripting, created by Radformation.
EZFluence is an automatic 3D planning software that can be utilized for any treatment site, but is
commonly used for radiation treatment planning of breast cancer9. EZFluence strives to simplify
treatment planning by automatically generating an optimal fluence file that can be then translated
into a FIF plan. The plan is then directly imported into Varian’s Eclipse treatment planning
software.
One study evaluates the usefulness of EZFluence in breast planning. It is limited to
opposing tangential fields only. The study examines the amount of time saved using EZFluence
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to plan, dose uniformity, dose to organs at risk, and the total number of Monitor Units (MUs)
based on the planning of 20 breast cancer patients treated using tangential fields after breast
conservation surgery. The results concluded that EZFluence could create a comparable plan to
the FIF plan based on dose to OARs and homogeneity, but the time savings was
significant. When using EZFluence, the time required to create the opposing tangent plan
decreased by approximately 30 minutes using manual FIF technique to less than 4 minutes using
EZFluence, which equates to a time savings of 84.6%10. There is a gap in the research on the
utility of EZFluence when three or more fields are needed for breast planning. Another study
was completed using the author’s own version of an auto-planning script. The auto-planning
software was evaluated for time efficiency but was not compared against manual planning. The
research reports that 50% of the plans were accepted by the treating physicians, while only minor
changes were requested on the other 50% of the treatment plans. Initially, the script took around
52 minutes to plan the 3-field breasts, but they estimated that they would be able to improve the
time to under 20 minutes once it was employed on better servers in the clinic11.

Hypothesis
The purpose of this study is to evaluate the efficiency and accuracy of automated
planning scripts when applied to 3 field breast treatments.
Null Hypothesis: The null hypothesis is that there is a difference in time savings and
dose to OARs when using automated planning.
Alternative Hypothesis: The alternative hypothesis is that there is not a difference in
time savings and dose to OARs when using automated planning.
In a busy radiation therapy clinic, efficiency is key. Eliminating the time spent on creating and
editing treatment plans by using an auto-planning software frees up the medical dosimetrist,
6

allowing them to work on other assignments. When compared to manual FIF technique, what
time saving effect does EZFluence provide when planning a 3-field breast? Is EZFluence able
to meet the dose constraints for the organs at risk while delivering prescribed dose coverage to
the PTV? What quantitative advantage does EZFluence provide to the dose constraints when
compared to manual FIF technique?

Methods and Materials
Patient Selection
This is a retrospective study where ten previously treated breast cancer patients were
selected and anonymized using the Eclipse treatment planning software (TPS). The anonymized
data was submitted for this research through an honest broker. Patients included in the study
were intact breast patients with supraclavicular nodal involvement, over the age of 18 years, and
not pregnant at the time of their initial treatment. A total of 5 left-sided and 5 right-sided
patients were chosen for the study.

Ethical Considerations
The proposal for the study was submitted to the Institutional Review Board (IRB) at
McLeod Regional Medical Center (MRMC). MRMC’s IRB approved the proposal, which was
then submitted to the IRB at Grand Valley State University (GVSU). GVSU’s IRB also
approved the proposal, with the condition that the patients used for the study would be
anonymized by an honest broker.
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Simulation
All patients were simulated using a Toshiba Aquilion CT scanner in a supine position
with the ipsilateral arm raised above the head, utilizing a VacLok bag to immobilize the patient.
The patient’s head was slightly rotated to face the contralateral side. Radiopaque BB markers
were placed on the medial and lateral aspect of the affected breast to determine biangulation.
Radiopaque wires were placed 2 centimeters superior and inferior to the breast tissue by the
treating physician. Scans were acquired at 3 mm slice thickness and sent to the treatment
planning system (TPS) for contouring and planning.

Contouring
Target structures, which included the clinical target volume for the breast (CTV_Brst)
and supraclavicular nodes (CTV_SCV), were contoured during the patient’s initial treatment
planning phase by the radiation oncologist. A qualified medical dosimetrist delineated the
nearby organs at risk, per the RTOG contouring atlas. These structures included bilateral lungs,
ipsilateral lung, spinal cord, esophagus, and heart.

Planning
Patients were planned using a three-field 3D conformal technique, utilizing a
monoisocentric setup when possible. If the monoisocentric technique could not be achieved due
to field size, a dual isocenter technique was used. For a monoisocentric technique, the isocenter
was placed where the supraclavicular CTV and breast CTV met anatomically at the level of the
clavicular head. The isocenter was placed one centimeter laterally to the ribs and to a depth of
approximately 7 centimeters. The supraclavicular field was created with a 1 centimeter margin
8

around the physician’s supraclavicular CTV superiorly, medially, and laterally, and matched to
the tangential field border inferiorly. The supraclavicular field was created using a gantry angle
of 10-15 degrees to displace the CTV_SCV volume away from the spinal cord. Care was taken
to block the humeral head and the spinal cord using the MLCs. Tangential breast fields were
created by utilizing a half beam block technique and matching to the inferior border of the
supraclavicular field superiorly, creating 2 centimeters of flash anteriorly beyond the breast
tissue, and utilizing a 0.6-0.8-centimeter block margin behind the breast CTV posteriorly. The
gantry angles of the tangential fields were created by directing the beam angle through the
medial and lateral radiopaque BB’s placed by the physician during CT simulation. Care was
taken to block the heart and lungs using MLCs, and in the case of left sided breast patients,
priority was given to blocking the heart rather than treating deep breast tissue in order to spare
dose to the heart. Field-in-field technique was used for both manual planning and EZFluence to
minimize hot spots and dose to OARs, with a maximum of four subfields per tangent and at least
5 monitor units per subfield.
For manually planning, the goal was to get rid of most, if not all, 107% dose within the
plan using field-in-field technique. Due to institutional standards, no more than 4 subfields per
open tangential field would be utilized, and each subfield was required to have a minimum of 5
monitor units. Institutional standards also provide guidance that the 95% isodose line should
meet the chest wall in order to be considered as an acceptable plan. For the supraclavicular
volume, the institution preferred that the 80% line cover the deep portion of the drawn
supraclavicular contour. Calculation points were used for both the breast and supraclavicular
volume. The calculation point for the supraclavicular volume was placed at a depth between 2-4
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centimeters, depending on the thickness of the patient. The calculation point for the breast
volume was placed in the superior portion of the breast, and as close to the chest wall as possible.
As a general rule, both calculation points were placed in tissue and at least 1 centimeter away
from bone, air, and field edges.
The primary tangential fields were used to manually start the field-in-field planning
technique. Using the beam’s eye view window, the contours for the 107% and 105% isodose
lines were turned on to visualize their distribution and location in the plan. A subfield was then
generated from the primary tangential field and the MLCs were manually manipulated to cover
the high dose regions. Minimizing the amount of 105% dose was attempted, taking care to avoid
creating areas where the 100% isodose line breaks up. Placing MLCs within 1 centimeter of the
calculation points was avoided.
When utilizing EZFluence software for planning, identical fields to the manual plan were
created. When prompted by EZFluence to select coverage for the supraclavicular volume, a hot
spot of 111% was selected and 80% coverage to the CTV_SCV was prescribed. Supraclavicular
coverage was evaluated to ensure that the volume was covered by the 80% isodose line, and
adjusted the monitor units as needed to reduce hot spots. For the tangential fields, the chest wall
coverage was pushed, and then selected a hot spot of 107% and coverage to 95%. Field
weighting was adjusted using the manual slider bar if necessary, and an adequate plan was
selected based on the 95% coverage to the breast CTV_Brst volume. A FIF plan was then
generated, with a minimum of 5 MUs and a maximum of 4 segments or subfields per tangential
field. The plan was reviewed once generated and then exported back into Eclipse for evaluation.
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After exporting the plan back to Eclipse, no changes were made to the plan in order to
adequately evaluate the abilities of EZFluence to create a clinically acceptable treatment plan.
The time necessary for EZFluence to generate a plan was measured from the time the
software was opened to the export of the automatically generated plan. The time was recorded
and then compared to the time for manual planning. Manual planning time was measured from
the time that the manual planner began to create the first FIF. Dose to OARs was evaluated
using a DVH and compared to the doses from manual planning. Global max dose wase recorded
and evaluated between planning techniques. The volume receiving greater than 105% of the
prescription dose was also evaluated.
Doses to the organs at risk (OARs) were evaluated using the dose volume histogram
(DVH) for each plan and then compared. Coverage at the delineated targets were measured
using the metrics of CTV breast coverage at 95% dose and CTV supraclavicular coverage at
80% dose. Dose constraints were measured for heart mean, total lung V20, ipsilateral lung V20,
spinal cord maximum dose, esophagus mean, amount of 5350 cGy within the plan and the global
heat maximum. Time required to plan for the dosimetrist and for the automated software were
also evaluated to demonstrate efficiency.

Statistical Analysis
Manual and an automated treatment technique were used to generate a clinically relevant
field-in-field three-field breast plan. These techniques were evaluated based on quality and the
time it took to generate the plans. Statistical analysis was conducted using a paired data t-test
and SPSS software.
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RESULTS
The goal of this study was to evaluate the time savings when comparing planning
techniques for a human planner versus an automated planning software. This study specifically
focused on three-field breast techniques, utilizing Radformation’s EZFluence software. Of the
10 patients that were retrospectively planned in the study, 5 were left-sided and 5 were rightsided. In addition to planning time, dose coverage to the breast and supraclavicular CTVs, as
well as dose to nearby OARs were measured to ensure plan quality.
When comparing the plans created, the automated planning software was, on average,
33.3 minutes faster than the human planner (P = 0.002). For the breast CTV, the average volume
receiving 95% of the prescription dose was only 0.2% higher for EZFluence than the human
planner (P = 0.754). For the supraclavicular CTV, the average volume receiving 80% of the
prescription dose was 0.9% higher for EZFluence than the human planner (P = 1.000).
Maximum dose within the plan was measured, and on average, the automated planning software
was around 2.4% higher than the manual planner (P = 0.109). The volume of 107% heat in the
plan was also measured, and the mean volume was 27.2 cc higher for the plans created in
EZFluence compared to the human created plans (P = 0.021).
On average, dose received to the total lung volume was equal for both EZFluence and the
human planner (P = 0.021). For the ipsilateral lung on the affected side, mean dose was 0.1%
higher for the human planner than EZFluence (P = 1.000). Average maximum dose to the spinal
cord was 19.5 cGy higher in the plans created by EZFluence as compared to the plans created by
the human (P = 0.344). Average dose to the esophagus was 0.1 cGy higher in the plans created
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by the human as compared to the EZFluence generated plans (P = 1.000). Mean dose to the heart
was on average 1.8 cGy higher in the plans created by the human (P = 0.508).

DISCUSSION
As stated previously, the EZFluence software was an average of 33.3 minutes faster than
the manual planner on the 10 retrospective breast plans. This was similar to a study completed
by Dragojević et al., which states that EZFluence averaged 6 minutes for a breast plan, while it
took a dosimetrist between one and three hours to plan a treatment for the same patient12.
However, speed isn’t the most important aspect of a treatment plan. Coverage of the CTV_Brst
and CTV_SCV volume were evaluated and compared between the manual planner and the
software for any statistical significance. Overall, EZFluence had better coverage to the two
structures, but by less than a full percentage.
When evaluating volume covered by the prescription dose, consideration needs to be
taken for the maximum global dose that exists within the plan and the absolute volume of the
dose. EZFluence had a maximum global dose that was on average 2.9% higher than the manual
planner and the amount of tissue irradiated by over 5350 cGy (107%) was on average 27.2 cc
higher in the EZFluence plans. This concludes that in order to get essentially the same coverage
to the CTVs, EZFluence had to allow more high dose to exist in the plan, which would also
result in a higher overall global maximum dose, or hot spot.
Due to the nature of the study, the manual planner did not make any manual edits to the
FIF plans that EZFluence was creating. The higher amount of 5350 cGy in the plan could,
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however, be reduced by the manual planner before exporting the plan from EZFluence into
Eclipse. This would require more of the manual planner’s time, but it would still result in less
overall planning time.
When evaluating the doses to the OARs, there is no statistical significance in the
difference between the manual plan and EZFluence for both the total and ipsilateral lung. This is
due to the original tangential fields being congruent for both plans.
There is also no statistical significance in the difference between the average doses to the
spinal cord in both the manual plans and the plans created by EZFluence. The majority of the
dose received by the spinal cord comes from the supraclavicular field, and similarly to the total
and ipsilateral lung. The main factor of the dose received, is due to the initial shaping of the
field, which is the same for both plans. Dose would only be reduced in one of the plans by using
FIF technique to use the MLCs and jaws to cover more of the spinal cord. Another factor is that
EZFluence did not create a FIF for any of the supraclavicular plans, the plan was only adjusted
by reducing MUs to reduce high dose regions. In the manual plans, FIFs were created in the
supraclavicular region to reduce high dose in the plan, which could also have resulted in a
reduced dose to the spinal cord.
During three field breast treatments, it is common for the esophagus to receive a higher
average dose than during a typical breast only treatment. This is due to the addition of the
supraclavicular field, and the location of the esophagus in relation to the spinal cord.
The heart mean should be higher for left-sided breast patients than for right-sided patients
due to the location of the heart in the body. In this study, only 5 of the 10 total patients were leftsided treatments, so heart mean was recorded for all 10 patients because even right-sided patients
14

still receive some dose to the heart. The heart is mostly blocked using the tangential fields, but
can be further blocked using the MLCs during FIF planning. Because of this, the difference in
heart mean between the manual planner and EZFluence was not statistically significant.
Limitations of the study include population size. Also, comfort and experience with the
EZFluence software. More than 10 patients would provide a more accurate average dose to the
CTVs and OARs. It would also provide more information on mean heart dose when evaluating
left-sided breast patients.
Opportunities for further research could include overall time savings when the exported
EZFluence plan is then further adjusted by the dosimetrist, as this study only focused on the
original plan that EZFluence created. It would also be beneficial to focus only on left-sided or
right-sided patients, as averaging the two together doesn’t accurately depict average dose to the
heart.

CONCLUSION
EZFluence is, on average, faster than a manual planner and does provide a clinically
acceptable treatment plan for three-field breast treatments. There were no statistically significant
differences in doses to surrounding OARs between the two plans, however, the plans created by
EZFluence typically had a higher hot spot and an increased volume of 107% dose than the plan
that was manually created. Using a combination of a plan created by EZFluence and then
manually edited by a dosimetrist would create greater efficiency in a medical dosimetry
department, which would allow more overall plans to be completed.
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